Subscribe to RSS - home infusion

home infusion

Study: Patient monitoring limits adverse drug effects

 - 
03/22/2016

NEW ORLEANS – Close monitoring of patients receiving infusions of infliximab prevented adverse drug events, according to a new study from Option Care.

Hospital system buys Pittsburgh home infusion pharmacy

 - 
03/17/2016

PITTSBURGH, Pa. – Allegheny Health Network, a nonprofit hospital system, has expanded its home health business by acquiring a home infusion pharmacy in Sharpsburg, Pa., from Infusion Partners, a subsidiary of Elmsford, N.Y.-based BioScrip.

PromptCare buys Boston Home Infusion

 - 
03/04/2016

CLARK, N.J. – PromptCare has bought Stoughton, Mass.-based Boston Home Infusion. The deal will help PromptCare, whose presence spans from the mid-Atlantic to the Northeastern U.S., expand respiratory services to the greater Boston area.

Oxford Finance closes $50M credit facility for home infusion provider

 - 
03/02/2016

ALEXANDRIA, Va. – Oxford Finance has served as a co-lender and documentation agent for the closing of a $35 million term loan and a $15 million revolving line of credit for Superior Biologics, a home infusion and specialty pharmacy provider.

NHIA finalizes data definitions

 - 
02/26/2016

ALEXANDRIA, Va. – The National Home Infusion Association has released its final set of Standard Definitions for Patient Outcomes Data to establish national benchmarks.

PharMerica’s revenues, income blow up

 - 
02/26/2016

LOUISVILLE, Ky. – PharMerica Corp., a provider of pharmacy services, including specialty home infusion, has reported fourth quarter revenues of $520.6 million compared to $523.5 million for the same period in 2014. Net income was $20.2 million vs. $3.2 million.

PharMerica closes year with two buys

 - 
12/22/2015

LOUISVILLE, Ky. – Amerita, a subsidiary of PharMerica, a national provider of institutional and specialty pharmacy services, has acquired Alternacare Infusion Pharmacy, an Olathe, Kan.-based specialty home infusion provider.

In brief: OIG targets Hoveround, CMS to revise fee schedule

 - 
12/04/2015

WASHINGTON – The Office of Inspector General (OIG) wants Hoveround to pay back the federal government $27 million for power mobility devices that it says do not meet Medicare reimbursement requirements.

BioScrip brings in turnaround team as losses mount

 - 
09/25/2015

ELMSFORD, N.Y. – BioScrip has tapped several new execs and beefed up its board of directors as it repositions itself as a pure play home infusion provider.

Pages